Teva's Copaxone approved for preventative treament of MS - The drug is already approved to treat relapsing-remitting multiple sclerosis, where new symptoms occur suddenly or older symptoms become …
Today’s Top Three in Pharma 012609
Of course, the huge news this Monday morning...Pfizer buying Wyeth. This will dominate the headlines for days. Before the deal was announced, Jim Edwards did some analysis on potential downsides - …